https://www.selleckchem.com/pr....oducts/Mizoribine.ht
Nonadherence to treatment, health motivations, self-efficacy for health management and the trust dimension of the patient-doctor RQ did not differ between groups. We conclude by discussing the low use of the most recent technologies in the CD population, although these technologies seem to provide access to health information that empowers patients and leads to a better relationship with their doctors. New remedies are required for the treatment of neuropathic pain due to insufficient efficacy of available therapies. This study provi